We Power Global Entrepreneurs

Global entrepreneurs think big from day one. Boston attracts the best and brightest, who like you hope to launch the next big technology or life science company. The Venture Development Center delivers the support you need when you need it, to turn your vision into reality, beginning with a startup visa.

The companies say it best

“The VDC offers an excellent environment in which to build our company. The staff has been phenomenal in their commitment to the unique needs of a startup. They have a great track record with companies and we are inspired by all the innovative work our neighbors in the space are doing.”
Armon Sharei, CEO, SQZ Biotech

Within 18 months at the VDC, SQZ landed a Series A from Polaris, closed a $500M cancer deal with Roche, and grew from 6 to 30 persons.

Join our thriving community

SQZ turns immune cells into cancer killers

A spinoff of the Langer Lab at MIT, SQZ has demonstrated the ability to overcome many of the long standing challenges in the field of intracellular delivery. Founder Armon Sharei is from California.

Ori makes extreme urban living comfortable

Ori’s robotic furniture makes a tiny apartment two times that size. Spinoff of the MIT Media Lab. Co-founders Ivan Fernandez de Casadevante and Hasier Larrea are from Spain.

Platelet Biogenesis expands life-saving platelet availability

No longer do volunteers have to roll up their sleeves to save a life. Platelet is a spinoff of Brigham and Woman’s Hospital. Founder Jonathan Thon is from Canada.

doDOC makes documents secure, collaborative and audit-ready

TechStars graduate doDOC magically pulls information together from multiple sources into one document for regulatory filings. Founders Carlos Boto, Federico Cismondi and Paulo Melo are from Portugal.

A smarter system for manufacturing modular buildings

Fluxus is an emerging innovator in prefabricated buildings. Founder Fanyu Lin, a Columbia University graduate, is from China.

RistCall transforms patient communication

Say goodbye to the call-bell. RistCall’s platform connects patients and nurses wherever they are in the hospital. Founders Srinath Vaddepally and Ameya Bhat, from India, graduated from Carnegie Mellon University.

Execute smartly with experienced entrepreneurs by your side

You’ll have unprecedented access to those who have already succeeded in executing a big vision. Our entrepreneurs-in-residence have worked with over 1,000 startups from the ground up. 

Grow cost-effectively in a facility that satisfies every need and desire

Our facility is designed to help you obtain the data required to secure further investment, launch your company and grow to the next level. Every imaginable type of instrument and workspace for technology and life science is at your disposal.

Need a visa to start your journey?

With a cap-exempt H-1B visa sponsored by UMass, you can stay in the country after you graduate and grow your business.

By the numbers


Money Raised by Companies

Employees at Companies


Companies Still Active

Latest news

Boston biotech startup SQZ seals a $500M deal with drug giant Roche

Boston-based SQZ Biotech hasn’t even moved out of its incubator space at the Venture Development Center at the University of Massachusetts. Yet the deal with Roche is one that would be transformative for most of the areas’ larger, publicly-traded biotech firms.

CloudHealth Scoops Up $20M, Eyes IPO

The latest investment was led by new backer Sapphire Ventures, with contributions from previous CloudHealth investors Scale Venture Partners, .406 Ventures, and Sigma Prime Ventures. Now, the plan is to keep the foot on the gas. CloudHealth intends to grow its staff to over 150 people by the end of the year.

Platelet BioGenesis awarded $1.5 million SBIR grant

Platelet BioGenesis announced that it has received a Small Business Innovation Research (SBIR) grant valued at $1.5 million from the National Heart, Lung, and Blood Institute. By transitioning to a donor-independent system, patients will have access to safer platelets and will no longer be dependent on volunteer donors.

Gene-editing record smashed in pigs by eGenesis

For decades, scientists and doctors have dreamed of creating a steady supply of human organs for transplantation by growing them in pigs. Now, by modifying more than 60 genes in pig embryos — ten times more than have been edited in any other animal — researchers at eGenesis believe they may have produced a suitable non-human organ donor.

Want to join our community?